{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:52:45Z","timestamp":1775620365365,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002261","name":"\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u0424\u043e\u043d\u0434 \u0424\u0443\u043d\u0434\u0430\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u044b\u0445 \u0418\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439","doi-asserted-by":"publisher","award":["18-29-09046"],"award-info":[{"award-number":["18-29-09046"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11033-020-05612-2","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T07:02:35Z","timestamp":1593414155000},"page":"5315-5321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["New germline mutations in non-BRCA genes among breast cancer women of Mongoloid origin"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0051-8814","authenticated-orcid":false,"given":"Polina","family":"Gervas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksey","family":"Molokov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Schegoleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artem","family":"Kiselev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya","family":"Babyshkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubov","family":"Pisareva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yury","family":"Tyukalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Choynzonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezda","family":"Cherdyntseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"issue":"1","key":"5612_CR1","doi-asserted-by":"crossref","first-page":"17769","DOI":"10.1038\/s41598-019-54170-6","volume":"9","author":"J Dutil","year":"2019","unstructured":"Dutil J, Teer JK, Golubeva V, Yoder S et al (2019) Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico. Sci Rep 9(1):17769","journal-title":"Sci Rep"},{"key":"5612_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40661-017-0039-8","volume":"4","author":"MK Frey","year":"2017","unstructured":"Frey MK, Pothuri B (2017) Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature. Gynecol Oncol Res Pract 4:4","journal-title":"Gynecol Oncol Res Pract"},{"key":"5612_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2019.11.014","volume":"76","author":"M Rodr\u00edguez-Balada","year":"2020","unstructured":"Rodr\u00edguez-Balada M, Roig B, Mel\u00e9 M, Albacar C et al (2020) Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients. Clin Biochem 76:17\u201323","journal-title":"Clin Biochem"},{"key":"5612_CR4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.canlet.2010.07.013","volume":"298","author":"AG Iyevleva","year":"2010","unstructured":"Iyevleva AG, Suspitsin EN, Kroeze K, Gorodnova TV et al (2010) Non-founder BRCA1 mutations in Russian breast cancer patients. Cancer Lett 298:258\u2013263","journal-title":"Cancer Lett"},{"key":"5612_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canlet.2015.01.022","volume":"359","author":"AP Sokolenko","year":"2015","unstructured":"Sokolenko AP, Preobrazhenskaya EV, Aleksakhina SN, Iyevleva AG et al (2015) Candidate gene analysis of BRCA1\/2 mutation-negative high-risk Russian breast cancer patients. Cancer Lett 359:259\u2013261","journal-title":"Cancer Lett"},{"key":"5612_CR6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.15690\/vramn.v69i11-12.1186","volume":"11\u201312","author":"NV Cherdyntseva","year":"2014","unstructured":"Cherdyntseva NV, Pisareva LF, Ivanova A, Panferova Y et al (2014) Ethnic aspects of hereditary breast cancer in the region of Siberia. Vestn Ross Akad Med Nauk 11\u201312:72\u201379","journal-title":"Vestn Ross Akad Med Nauk"},{"key":"5612_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/CBM-161649","volume":"18","author":"N Cherdyntseva","year":"2017","unstructured":"Cherdyntseva N, Gervas P, Voropaeva E, Denisov E et al (2017) New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: report from two families. Cancer Biomark 18:291\u2013296","journal-title":"Cancer Biomark"},{"issue":"5","key":"5612_CR8","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1007\/s11033-019-04928-y","volume":"46","author":"P Gervas","year":"2019","unstructured":"Gervas P, Klyuch B, Denisov E, Kiselev A et al (2019) New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients. Mol Biol Rep 46(5):5537\u20135541","journal-title":"Mol Biol Rep"},{"key":"5612_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R et al (2013) From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinform 43:11","journal-title":"Curr Protoc Bioinform"},{"key":"5612_CR10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43:491\u2013498","journal-title":"Nat Genet"},{"key":"5612_CR11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A et al (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297\u20131303","journal-title":"Genome Res"},{"issue":"4","key":"5612_CR12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248\u2013249","journal-title":"Nat Methods"},{"issue":"4","key":"5612_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361\u2013362","journal-title":"Nat Methods"},{"key":"5612_CR14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073\u20131081","journal-title":"Nat Protoc"},{"issue":"4","key":"5612_CR15","first-page":"11","volume":"10","author":"OA Kiseleva","year":"2013","unstructured":"Kiseleva OA, Robustova OV, Bessmertny AM, Zakharova EK, Avdeev RV (2013) Prevalence of primary glaucoma in representatives of different races and ethnic groups in Russia and in CIS. Ophthalmology 10(4):11\u201315","journal-title":"Ophthalmology"},{"key":"5612_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jmedgenet-2015-103132","volume":"53","author":"A Kwong","year":"2016","unstructured":"Kwong A, Shin VY, Ho JC, Kang E et al (2016) Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. J Med Genet 53:15\u201323","journal-title":"J Med Genet"},{"key":"5612_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000441714","volume":"19","author":"S Nakamura","year":"2016","unstructured":"Nakamura S, Kwong A, Kim SW et al (2016) Current status of the management of hereditary breast and ovarian cancer in Asia: first report by the Asian BRCA Consortium. Public Health Genomics 19:53\u201360","journal-title":"Public Health Genomics"},{"key":"5612_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/humu.9015","volume":"19","author":"US Khoo","year":"2002","unstructured":"Khoo US, Chan KY, Cheung AN, Xue WC et al (2002) Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat 19:307\u2013308","journal-title":"Hum Mutat"},{"key":"5612_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-0004.2010.01545.x","volume":"80","author":"OM Ginsburg","year":"2011","unstructured":"Ginsburg OM, Dinh NV, To TV, Quang LH et al (2011) Family history, BRCA mutations and breast cancer in Vietnamese women. Clin Gene 80:89\u201392","journal-title":"Clin Gene"},{"key":"5612_CR20","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.18632\/oncotarget.7144","volume":"7","author":"YC Kim","year":"2016","unstructured":"Kim YC, Zhao L, Zhang H, Huang Y et al (2016) Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients. Oncotarget 7:9600\u20139612","journal-title":"Oncotarget"},{"issue":"20","key":"5612_CR21","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1158\/1078-0432.CCR-16-3227","volume":"23","author":"J Sun","year":"2017","unstructured":"Sun J, Meng H, Yao L, Lv M, Bai J et al (2017) Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res 23(20):6113\u20136119","journal-title":"Clin Cancer Res"},{"issue":"9","key":"5612_CR22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","volume":"43","author":"C Loveday","year":"2011","unstructured":"Loveday C, Turnbull C, Ramsay E, Hughes D et al (2011) Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet 43(9):879\u2013882","journal-title":"Nat Genet"},{"issue":"1","key":"5612_CR23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1897-4287-11-8","volume":"11","author":"L Paparo","year":"2013","unstructured":"Paparo L, Rossi GB, Delrio P, Rega D et al (2013) Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndrome. Hered Cancer Clin Pract 11(1):8","journal-title":"Hered Cancer Clin Pract"},{"issue":"10","key":"5612_CR24","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1158\/0008-5472.CAN-12-3811","volume":"73","author":"X He","year":"2013","unstructured":"He X, Arrotta N, Radhakrishnan D, Wang Y et al (2013) Cowden syndrome-related mutations in PTEN associate with enhanced proteasome activity. Cancer Res 73(10):3029\u20133040","journal-title":"Cancer Res"},{"key":"5612_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2350-13-28","volume":"13","author":"M Galatola","year":"2012","unstructured":"Galatola M, Paparo L, Duraturo F, Turano M et al (2012) Beta catenin and cytokine pathway dysregulation in patients with manifestations of the \"PTEN hamartoma tumor syndrome\". BMC Med Genet 13:28","journal-title":"BMC Med Genet"},{"issue":"4","key":"5612_CR26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ophtha.2011.09.057","volume":"119","author":"G Venturini","year":"2012","unstructured":"Venturini G, Moulin AP, Deprez M, Uffer S et al (2012) Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome. Ophthalmology 119(4):857\u2013864","journal-title":"Ophthalmology"},{"issue":"8","key":"5612_CR27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jmg.2011.088807","volume":"48","author":"R Pilarski","year":"2011","unstructured":"Pilarski R, Stephens JA, Noss R, Fisher JL, Prior TW (2011) Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet 48(8):505\u2013512","journal-title":"J Med Genet"},{"issue":"1","key":"5612_CR28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","volume":"88","author":"MH Tan","year":"2011","unstructured":"Tan MH, Mester J, Peterson C, Yang Y et al (2011) A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 88(1):42\u201356","journal-title":"Am J Hum Genet"},{"issue":"6","key":"5612_CR29","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1365-2133.2000.03533.x","volume":"142","author":"Y Kubo","year":"2000","unstructured":"Kubo Y, Urano Y, Hida Y, Ikeuchi T et al (2000) A novel PTEN mutation in a Japanese patient with Cowden disease. Br J Dermatol 142(6):1100\u20131105","journal-title":"Br J Dermatol"},{"issue":"1","key":"5612_CR30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jso.23735","volume":"111","author":"J Mester","year":"2015","unstructured":"Mester J, Eng C (2015) Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome. J Surg Oncol 111(1):125\u2013130","journal-title":"J Surg Oncol"},{"issue":"2","key":"5612_CR31","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jcmm.14861","volume":"24","author":"J Cheng","year":"2020","unstructured":"Cheng J, Peng J, Fu J, Khan A, Tan P, Wei C, Deng X, Chen H, Fu J (2020) Identification of a novel germline BRCA2 variant in a Chinese breast cancer family. J Cell Mol Med 24(2):1676\u20131683","journal-title":"J Cell Mol Med"},{"issue":"11","key":"5612_CR32","first-page":"1564","volume":"39","author":"VA Stepanov","year":"2003","unstructured":"Stepanov VA, Spiridonova MG, Puzyrev VP (2003) Comparative phylogenetic study of native north Eurasian populations from a panel of autosomal microsatellite loci. Genetika 39(11):1564\u20131572","journal-title":"Genetika"},{"issue":"10","key":"5612_CR33","first-page":"1381","volume":"39","author":"VA Stepanov","year":"2003","unstructured":"Stepanov VA, Spiridonova MG, Tadinova VN, Puzyrev VP (2003) Analysis of genetic diversity of population of Northern Eurasia from autosomal microsatellite loci. Genetika 39(10):1381\u20131388","journal-title":"Genetika"},{"issue":"2","key":"5612_CR34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7868\/S0016675813110088","volume":"50","author":"VN Har'kov","year":"2014","unstructured":"Har'kov VN, Hamina KV, Medvedeva OF (2014) Gene pool of Buryats: clinal variability and territorial subdivision based on data of Y-chromosome markers. Genetika 50(2):203\u2013213","journal-title":"Genetika"},{"issue":"5","key":"5612_CR35","first-page":"804","volume":"44","author":"II Khitrinskaia","year":"2010","unstructured":"Khitrinskaia II, Khar'kov VN, Stepanov VA (2010) Genetic diversity of X-chromosome in populations of aboriginal Siberian ethnic groups: linkage disequilibrium structure and haplotype philogeography of ZFX locus. Mol Biol (Mosk) 44(5):804\u2013815","journal-title":"Mol Biol (Mosk)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05612-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05612-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05612-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T17:06:34Z","timestamp":1723136794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05612-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5612"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05612-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"5 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The current study was approved by the review board of the Cancer Research Institute, and written informed consent was obtained from all patients and in compliance with the recommendations of the Helsinki Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}